ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2019

Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study.

Shanshan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.